Article
Injectable PrEP and COVID show we're all in this together
Rating:
0.0
Views:
77
Likes:
1
Library:
1
Just before Christmas, the US Food and Drug Administration (FDA) announced that it had approved an injectable formulation of the HIV drug cabotegravir for use as PrEP. The drug, to be given as an injection every two months, will be branded as Apretude in the US. Although FDA approval came earlier than expected, they could have hardly rejected it.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value